Status:
UNKNOWN
Efficacy of Probiotic Capsules With Topical Clobetasol Propionate in OLP Treatment
Lead Sponsor:
October 6 University
Collaborating Sponsors:
Cairo University
Conditions:
Oral Lichen Planus
Eligibility:
All Genders
20-75 years
Phase:
PHASE3
Brief Summary
Oral lichen planus patients who will meet inclusion criteria will be divided into 2 groups -The intervention group (Group P): This group will be randomly allocated to take one capsule twice daily dur...
Eligibility Criteria
Inclusion
- Patients who are diagnosed with symptomatic lichen planus whether bullous erosive or erythematous oral lichen planus.
- Male or female patient with age range between 20-75 years old were included.
- medically free individuals
Exclusion
- the use of systemic antibiotics, corticosteroids or immunosuppressive agents within four weeks prior to enrollment in the study.
- Pregnant females
- patients with history of systemic disorder affecting the immune system
- active liver diseases and cancer
- allergy or intolerance to probiotics.
- any other oral lesions
Key Trial Info
Start Date :
May 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2023
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT06119672
Start Date
May 1 2023
End Date
December 30 2023
Last Update
November 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University
Cairo, Egypt, +2